| Lucas Kane, DO | |
|
1308 Tuscaloosa Ave Sw, Birmingham, AL 35211-1948 | |
| (205) 679-6325 | |
| Not Available |
| Full Name | Lucas Kane |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 5 Years |
| Location | 1308 Tuscaloosa Ave Sw, Birmingham, Alabama |
| Accepts Medicare Assignments | May be. He may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1306405576 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | DO.2745 (Alabama) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Cahaba Medical Care Foundation | 1355597923 | 83 |
News Archive
Identifying gene mutations in cancer patients to predict clinical outcome has been the cornerstone of cancer research for nearly three decades, but now researchers at the Kimmel Cancer Center at Jefferson have invented a new approach that instead links cancer cell metabolism with poor clinical outcome. This approach can now be applied to virtually any type of human cancer cell.
Nationwide Children's Hospital today announced that it has received a $10 million gift from the Nationwide Insurance Foundation.
CorMedix Inc., a pharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of cardiorenal disease, announced it successfully completed patient enrollment in its phase II Contrast-Induced Acute Kidney Injury study with its oral drug candidate CRMD001.
Bioengineers at the University of California, San Diego have discovered that mouse embryos are contemplating their cellular fates in the earliest stages after fertilization when the embryo has only two to four cells, a discovery that could upend the scientific consensus about when embryonic cells begin differentiating into cell types.
› Verified 7 days ago
| Entity Name | Whatley Health Services Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1063422756 PECOS PAC ID: 8224921705 Enrollment ID: O20040206000846 |
News Archive
Identifying gene mutations in cancer patients to predict clinical outcome has been the cornerstone of cancer research for nearly three decades, but now researchers at the Kimmel Cancer Center at Jefferson have invented a new approach that instead links cancer cell metabolism with poor clinical outcome. This approach can now be applied to virtually any type of human cancer cell.
Nationwide Children's Hospital today announced that it has received a $10 million gift from the Nationwide Insurance Foundation.
CorMedix Inc., a pharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of cardiorenal disease, announced it successfully completed patient enrollment in its phase II Contrast-Induced Acute Kidney Injury study with its oral drug candidate CRMD001.
Bioengineers at the University of California, San Diego have discovered that mouse embryos are contemplating their cellular fates in the earliest stages after fertilization when the embryo has only two to four cells, a discovery that could upend the scientific consensus about when embryonic cells begin differentiating into cell types.
› Verified 7 days ago
| Entity Name | Capstone Health Services Foundation Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1740397751 PECOS PAC ID: 6103724489 Enrollment ID: O20040330001160 |
News Archive
Identifying gene mutations in cancer patients to predict clinical outcome has been the cornerstone of cancer research for nearly three decades, but now researchers at the Kimmel Cancer Center at Jefferson have invented a new approach that instead links cancer cell metabolism with poor clinical outcome. This approach can now be applied to virtually any type of human cancer cell.
Nationwide Children's Hospital today announced that it has received a $10 million gift from the Nationwide Insurance Foundation.
CorMedix Inc., a pharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of cardiorenal disease, announced it successfully completed patient enrollment in its phase II Contrast-Induced Acute Kidney Injury study with its oral drug candidate CRMD001.
Bioengineers at the University of California, San Diego have discovered that mouse embryos are contemplating their cellular fates in the earliest stages after fertilization when the embryo has only two to four cells, a discovery that could upend the scientific consensus about when embryonic cells begin differentiating into cell types.
› Verified 7 days ago
| Entity Name | Cahaba Medical Care Foundation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1316201809 PECOS PAC ID: 1355597923 Enrollment ID: O20121120000238 |
News Archive
Identifying gene mutations in cancer patients to predict clinical outcome has been the cornerstone of cancer research for nearly three decades, but now researchers at the Kimmel Cancer Center at Jefferson have invented a new approach that instead links cancer cell metabolism with poor clinical outcome. This approach can now be applied to virtually any type of human cancer cell.
Nationwide Children's Hospital today announced that it has received a $10 million gift from the Nationwide Insurance Foundation.
CorMedix Inc., a pharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of cardiorenal disease, announced it successfully completed patient enrollment in its phase II Contrast-Induced Acute Kidney Injury study with its oral drug candidate CRMD001.
Bioengineers at the University of California, San Diego have discovered that mouse embryos are contemplating their cellular fates in the earliest stages after fertilization when the embryo has only two to four cells, a discovery that could upend the scientific consensus about when embryonic cells begin differentiating into cell types.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Lucas Kane, DO 1308 Tuscaloosa Ave Sw, Birmingham, AL 35211-1948 Ph: (205) 679-6325 | Lucas Kane, DO 1308 Tuscaloosa Ave Sw, Birmingham, AL 35211-1948 Ph: (205) 679-6325 |
News Archive
Identifying gene mutations in cancer patients to predict clinical outcome has been the cornerstone of cancer research for nearly three decades, but now researchers at the Kimmel Cancer Center at Jefferson have invented a new approach that instead links cancer cell metabolism with poor clinical outcome. This approach can now be applied to virtually any type of human cancer cell.
Nationwide Children's Hospital today announced that it has received a $10 million gift from the Nationwide Insurance Foundation.
CorMedix Inc., a pharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of cardiorenal disease, announced it successfully completed patient enrollment in its phase II Contrast-Induced Acute Kidney Injury study with its oral drug candidate CRMD001.
Bioengineers at the University of California, San Diego have discovered that mouse embryos are contemplating their cellular fates in the earliest stages after fertilization when the embryo has only two to four cells, a discovery that could upend the scientific consensus about when embryonic cells begin differentiating into cell types.
› Verified 7 days ago
Mrs. Kathleen M Dupper, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1687 Center Point Pkwy Ste 121, Birmingham, AL 35215 Phone: 205-557-7022 Fax: 205-831-2849 | |
Jill Marsh, Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1717 6th Ave S, Birmingham, AL 35233 Phone: 800-822-8816 | |
Jack Cannon Whites, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 616 South 9th Street, Birmingham, AL 35233 Phone: 205-326-3100 Fax: 205-716-3044 | |
Dr. Kathryn D Kartus, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 3900 Seven Bark Cir, Birmingham, AL 35243 Phone: 205-967-6676 | |
Melissa Jane Puntkattalee, Family Medicine Medicare: Medicare Enrolled Practice Location: 5720 1st Ave S, Birmingham, AL 35212 Phone: 205-380-9455 Fax: 205-380-9459 | |
Dr. Nova Law, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 944 18th St S, Suite C, Birmingham, AL 35205 Phone: 205-870-4343 Fax: 205-870-0299 | |
Sarah Kane, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1308 Tuscaloosa Ave Sw, Birmingham, AL 35211 Phone: 205-679-6325 Fax: 205-783-8600 |